» Articles » PMID: 1717255

Functional Domains of the Granulocyte Colony-stimulating Factor Receptor

Overview
Journal EMBO J
Date 1991 Oct 1
PMID 1717255
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The granulocyte colony-stimulating factor (G-CSF) receptor has a composite structure consisting of an immunoglobulin(Ig)-like domain, a cytokine receptor-homologous (CRH) domain and three fibronectin type III (FNIII) domains in the extracellular region. Introduction of G-CSF receptor cDNA into IL-3-dependent murine myeloid cell line FDC-P1 and pro-B cell line BAF-B03, which normally do not respond to G-CSF, enabled them to proliferate in response to G-CSF. On the other hand, expression of the G-CSF receptor cDNA in the IL-2-dependent T cell line CTLL-2 did not enable it to grow in response to G-CSF, although G-CSF could transiently stimulate DNA synthesis. Mutational analyses of the G-CSF receptor in FDC-P1 cells indicated that the N-terminal half of the CRH domain was essential for the recognition of G-CSF, but the Ig-like, FNIII and cytoplasmic domains were not. The CRH domain and a portion of the cytoplasmic domain of about 100 amino acids in length were indispensable for transduction of the G-CSF-triggered growth signal.

Citing Articles

Granulocyte colony-stimulating factor protects against arthritogenic alphavirus pathogenesis in a type I IFN-dependent manner.

Hameed M, Hossain M, Daamen A, Lipsky P, Weger-Lucarelli J bioRxiv. 2024; .

PMID: 39416071 PMC: 11482922. DOI: 10.1101/2024.10.09.617470.


Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms.

Wang B, Mehta H, Penumutchu S, Tolbert B, Cheng C, Kimmel M Leukemia. 2022; 36(10):2499-2508.

PMID: 35941213 DOI: 10.1038/s41375-022-01672-4.


G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.

Karagiannidis I, Salataj E, Egal E, Beswick E Cytokine. 2021; 142:155479.

PMID: 33677228 PMC: 8044051. DOI: 10.1016/j.cyto.2021.155479.


Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function.

Bakherad H, Setayesh N, Mousavi Gargari S, Ebrahimizadeh W, Mavandadnejad F, Faghfuri E Res Pharm Sci. 2020; 15(4):381-389.

PMID: 33312216 PMC: 7714017. DOI: 10.4103/1735-5362.293516.


Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus.

Sivakumar R, Abboud G, Mathews C, Atkinson M, Morel L Front Immunol. 2018; 9:1053.

PMID: 29868014 PMC: 5954343. DOI: 10.3389/fimmu.2018.01053.


References
1.
Bishayee S, Majumdar S, Khire J, Das M . Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. J Biol Chem. 1989; 264(20):11699-705. View

2.
Fukunaga R, Nagata S . Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem. 1990; 265(23):14008-15. View

3.
Weinstein Y, Ihle J, Lavu S, Reddy E . Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line. Proc Natl Acad Sci U S A. 1986; 83(14):5010-4. PMC: 323879. DOI: 10.1073/pnas.83.14.5010. View

4.
Mosley B, Beckmann M, March C, Idzerda R, Gimpel S, Vandenbos T . The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell. 1989; 59(2):335-48. DOI: 10.1016/0092-8674(89)90295-x. View

5.
Nagata S, Tsuchiya M, Asano S, Yamamoto O, Hirata Y, Kubota N . The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor. EMBO J. 1986; 5(3):575-81. PMC: 1166801. DOI: 10.1002/j.1460-2075.1986.tb04249.x. View